Cytogen Ownership

217330 Stock  KRW 4,295  15.00  0.35%   
The market capitalization of Cytogen is W95.89 Billion. Cytogen retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Public60.58%Insiders39.37%I...100%
Some institutional investors establish a significant position in stocks such as Cytogen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cytogen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cytogen Stock Ownership Analysis

About 39.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Cytogen had 3:1 split on the 28th of September 2022. Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment and downstream systems to treat cancer in South Korea. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea. Cytogen is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Cytogen please contact the company at 82 2 6925 1070 or go to http://www.cytogenlab.com.

Cytogen Outstanding Bonds

Cytogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cytogen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cytogen bonds can be classified according to their maturity, which is the date when Cytogen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pair Trading with Cytogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Cytogen Stock

  0.6021240 COWAY CoPairCorr
  0.56058470 LEENO Industrial Earnings Call This WeekPairCorr
  0.5098460 Koh Young TechnologyPairCorr
  0.43225220 Genolution Earnings Call This WeekPairCorr
  0.42278650 KNOTUS CoLtdPairCorr
The ability to find closely correlated positions to Cytogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytogen to buy it.
The correlation of Cytogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Cytogen Stock

Cytogen financial ratios help investors to determine whether Cytogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytogen with respect to the benefits of owning Cytogen security.
News Freq…Investor S…